Your browser doesn't support javascript.
loading
Mutations driving CLL and their evolution in progression and relapse.
Landau, Dan A; Tausch, Eugen; Taylor-Weiner, Amaro N; Stewart, Chip; Reiter, Johannes G; Bahlo, Jasmin; Kluth, Sandra; Bozic, Ivana; Lawrence, Mike; Böttcher, Sebastian; Carter, Scott L; Cibulskis, Kristian; Mertens, Daniel; Sougnez, Carrie L; Rosenberg, Mara; Hess, Julian M; Edelmann, Jennifer; Kless, Sabrina; Kneba, Michael; Ritgen, Matthias; Fink, Anna; Fischer, Kirsten; Gabriel, Stacey; Lander, Eric S; Nowak, Martin A; Döhner, Hartmut; Hallek, Michael; Neuberg, Donna; Getz, Gad; Stilgenbauer, Stephan; Wu, Catherine J.
Afiliação
  • Landau DA; Broad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.
  • Tausch E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.
  • Taylor-Weiner AN; Department of Internal Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
  • Stewart C; Harvard Medical School, Boston, Massachusetts 02115, USA.
  • Reiter JG; Department of Internal Medicine III, Ulm University, Ulm 89081, Germany.
  • Bahlo J; Broad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.
  • Kluth S; Broad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.
  • Bozic I; Broad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.
  • Lawrence M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.
  • Böttcher S; IST Austria (Institute of Science and Technology Austria), Klosterneuburg 3400, Austria.
  • Carter SL; Program for Evolutionary Dynamics, Harvard University, Cambridge 02138, Massachusetts, USA.
  • Cibulskis K; Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University Hospital, Cologne 50937, Germany.
  • Mertens D; Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University Hospital, Cologne 50937, Germany.
  • Sougnez CL; Program for Evolutionary Dynamics, Harvard University, Cambridge 02138, Massachusetts, USA.
  • Rosenberg M; Department of Mathematics, Harvard University, Cambridge, Massachusetts 02138, USA.
  • Hess JM; Broad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.
  • Edelmann J; Department of Internal Medicine II, University Hospital of Schleswig-Holstein, Campus Kiel, Kiel 24105, Germany.
  • Kless S; Broad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.
  • Kneba M; Joint Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA.
  • Ritgen M; Broad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.
  • Fink A; Department of Internal Medicine III, Ulm University, Ulm 89081, Germany.
  • Fischer K; Mechanisms of Leukemogenesis, German Cancer Research Center (DKFZ), Heidelberg 69121, Germany.
  • Gabriel S; Broad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.
  • Lander ES; Broad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.
  • Nowak MA; Broad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.
  • Döhner H; Department of Internal Medicine III, Ulm University, Ulm 89081, Germany.
  • Hallek M; Department of Internal Medicine III, Ulm University, Ulm 89081, Germany.
  • Neuberg D; Department of Internal Medicine II, University Hospital of Schleswig-Holstein, Campus Kiel, Kiel 24105, Germany.
  • Getz G; Department of Internal Medicine II, University Hospital of Schleswig-Holstein, Campus Kiel, Kiel 24105, Germany.
  • Stilgenbauer S; Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University Hospital, Cologne 50937, Germany.
  • Wu CJ; Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University Hospital, Cologne 50937, Germany.
Nature ; 526(7574): 525-30, 2015 Oct 22.
Article em En | MEDLINE | ID: mdl-26466571
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Progressão da Doença / Evolução Molecular / Mutação / Recidiva Local de Neoplasia Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Progressão da Doença / Evolução Molecular / Mutação / Recidiva Local de Neoplasia Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article